We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$826M
AUM Growth
-$12.2M
Cap. Flow
+$46.8M
Cap. Flow %
5.67%
Top 10 Hldgs %
31.84%
Holding
2,811
New
180
Increased
1,184
Reduced
708
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 13.18%
2 Healthcare 7.19%
3 Consumer Staples 7.15%
4 Financials 6.93%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLB icon
1351
Core Laboratories
CLB
$493M
$19K ﹤0.01%
605
DAVA icon
1352
Endava
DAVA
$153M
$19K ﹤0.01%
142
-13
-8% -$1.64K
ESNT icon
1353
Essent Group
ESNT
$6.21B
$19K ﹤0.01%
450
FOXF icon
1354
Fox Factory Holding Corp
FOXF
$801M
$19K ﹤0.01%
199
+88
+79% +$10.9K
FWRD icon
1355
Forward Air
FWRD
$467M
$19K ﹤0.01%
203
+187
+1,169% +$19.7K
IDCC icon
1356
InterDigital
IDCC
$6.72B
$19K ﹤0.01%
302
JBSS icon
1357
John B. Sanfilippo & Son
JBSS
$989M
$19K ﹤0.01%
+228
New +$18.9K
KRNT icon
1358
Kornit Digital
KRNT
$708M
$19K ﹤0.01%
234
+46
+24% +$4.44K
KWR icon
1359
Quaker Houghton
KWR
$2.67B
$19K ﹤0.01%
111
-20
-15% -$3.97K
MD icon
1360
Pediatrix Medical
MD
$2.21B
$19K ﹤0.01%
806
-41
-5% -$1K
MXL icon
1361
MaxLinear
MXL
$5.35B
$19K ﹤0.01%
317
+245
+340% +$14.9K
NKTR icon
1362
Nektar Therapeutics
NKTR
$2.39B
$19K ﹤0.01%
238
+167
+235% +$24.7K
NVAX icon
1363
Novavax
NVAX
$1.21B
$19K ﹤0.01%
262
+92
+54% +$8.2K
RIGL icon
1364
Rigel Pharmaceuticals
RIGL
$712M
$19K ﹤0.01%
+626
New +$16.9K
SFL icon
1365
SFL Corp
SFL
$1.61B
$19K ﹤0.01%
1,859
-54
-3% -$498
SQM icon
1366
Sociedad Química y Minera de Chile
SQM
$19.1B
$19K ﹤0.01%
218
-125
-36% -$8K
AJRD
1367
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$19K ﹤0.01%
490
+359
+274% +$14.3K
ABG icon
1368
Asbury Automotive
ABG
$4.49B
$18K ﹤0.01%
115
+34
+42% +$5.95K
BIPC icon
1369
Brookfield Infrastructure
BIPC
$5.23B
$18K ﹤0.01%
351
CPF icon
1370
Central Pacific Financial
CPF
$1.02B
$18K ﹤0.01%
634
CSTE icon
1371
Caesarstone
CSTE
$71.6M
$18K ﹤0.01%
1,758
+417
+31% +$4.94K
DEA
1372
Easterly Government Properties
DEA
$1.17B
$18K ﹤0.01%
335
-65
-16% -$3.45K
EPAC icon
1373
Enerpac Tool Group
EPAC
$1.9B
$18K ﹤0.01%
800
+788
+6,567% +$14.9K
GL icon
1374
Globe Life
GL
$13.9B
$18K ﹤0.01%
181
-4
-2% -$406
GNW icon
1375
Genworth Financial
GNW
$3.85B
$18K ﹤0.01%
4,697

Similar funds

Quadrant Capital Group's Q1 2022 Portfolio in Review

As of Q1 2022, Quadrant Capital Group held 2,811 positions worth $826M, down 1.5% from $838M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Quadrant Capital Group deployed $46.8M of net new capital in Q1 2022, opening 180 new positions and adding to 1,184 existing holdings. Its largest new stake was RiverNorth Opportunistic Municipal Income Fund: 900,000 shares worth $900K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Core 1-5 Year USD Bond ETF, an estimated $7.86M trimmed.

  • Quadrant Capital Group's largest Q1 2022 buy was RiverNorth Opportunistic Municipal Income Fund: 900,000 shares worth $900K.
  • Quadrant Capital Group added most to Vanguard Short-Term Bond ETF in Q1 2022, an estimated $9.88M increase.
  • Quadrant Capital Group's biggest Q1 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $7.86M.
  • Quadrant Capital Group fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $781K.
  • Quadrant Capital Group's ten largest holdings make up 32% of its $826M portfolio in Q1 2022.
  • Quadrant Capital Group opened 180 new positions and closed 182 in Q1 2022.
  • Quadrant Capital Group's portfolio value fell 1.5% quarter-over-quarter to $826M.

Based on Quadrant Capital Group's 13F filing for Q1 2022, filed 6 May 2022.